Company News 

Unilever, GSK on hunt for deals

Unilever, GSK on hunt for deals

Unilever’s (ULVR) chief executive, Paul Polman, may be set to retire in the new year, but he’s not taking a back-seat approach to dealmaking just yet. The consumer goods giant has agreed to buy GlaxoSmithKline’s (GSK) health food drinks portfolio in India, Bangladesh and 20 other predominantly Asian markets for €3.3bn (£2.94bn) via a cash and shares deal with its Indian subsidiary. The transaction should increase Unilever’s emerging markets footprint and expand its portfolio of health food products.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now